(RPRX) Royalty Pharma - Performance 34.8% in 12m

RPRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating -15.76%
#78 in Peer-Group
Rel. Strength 81.07%
#1441 in Stock-Universe
Total Return 12m 34.81%
#28 in Peer-Group
Total Return 5y -12.49%
#78 in Peer-Group
P/E Value
P/E Trailing 13.6
P/E Forward 11.2
High / Low USD
52 Week High 35.27 USD
52 Week Low 23.96 USD
Sentiment Value
VRO Trend Strength +-100 87.31
Buy/Sell Signal +-5 -0.85
Support / Resistance Levels
Support
Resistance
12m Total Return: RPRX (34.8%) vs XLV (-5.1%)
Total Return of Royalty Pharma versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (RPRX) Royalty Pharma - Performance 34.8% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
RPRX 4.34% 5.9% 6.22%
PHAT 20.5% 206% 120%
VTYX 0.0% 112% 81.6%
ALTS 3.27% 64.1% 127%

Long Term Performance

Symbol 6m 12m 5y
RPRX 41.2% 34.8% -12.5%
ALTS 172% 335% 234%
VRNA 116% 453% 1,673%
BGM 57.0% 276% -72.2%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics
-4.5% 145% 360% 61.3 55.3 0.61 23.7% -5.15%
LLY NYSE
Eli Lilly
12% -6.78% 514% 66.1 37 1.24 58.2% 18.9%
NVS NYSE
Novartis
10.1% 17.9% 81.6% 18.5 14 1.37 8.70% 9.2%
NOVN SW
Novartis
7.55% 7.58% 54.8% 18.7 14.1 1.38 9.80% 11.2%
SFZN SW
Siegfried Holding
-0.63% 2.28% 140% 26.1 25 1.48 77.8% 77.6%
GSK NYSE
GlaxoSmithKline
10% 4.92% 57.7% 19.9 9.2 0.4 -25.2% 3.11%
AZN NASDAQ
AstraZeneca
9.51% -4.27% 58.6% 28.9 15.9 0.96 52.7% 22.3%
IPN PA
Ipsen
2.14% -13% 54.2% 24.4 10.3 0.74 -6.40% -6.33%

Performance Comparison: RPRX vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RPRX
Total Return (including Dividends) RPRX XLV S&P 500
1 Month 5.90% 4.35% 1.11%
3 Months 6.22% -6.89% 5.58%
12 Months 34.81% -5.08% 10.51%
5 Years -12.49% 50.53% 109.12%

Trend Score (consistency of price movement) RPRX XLV S&P 500
1 Month 50.9% 65.8% 69.9%
3 Months 52.6% -72% 69.3%
12 Months 71% -62.2% 43.2%
5 Years -76.9% 88.5% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month #86 1.49% 4.74%
3 Month #71 14.08% 0.60%
12 Month #28 42.03% 21.99%
5 Years #83 -40.44% -57.35%

FAQs

Does Royalty Pharma (RPRX) outperform the market?

Yes, over the last 12 months RPRX made 34.81%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%. Over the last 3 months RPRX made 6.22%, while XLV made -6.89%.

Performance Comparison RPRX vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

RPRX vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 4.8% 4.8% 42.2% 24%
US NASDAQ 100 QQQ 5% 4.4% 43% 26%
German DAX 40 DAX 7% 6.7% 25.9% 5%
Shanghai Shenzhen CSI 300 CSI 300 5.1% 6.8% 40.4% 23%
Hongkong Hang Seng HSI 4.3% 0.9% 23.2% 7%
India NIFTY 50 INDA 6.5% 7.2% 43.2% 36%
Brasil Bovespa EWZ 2.5% 5.4% 22% 26%

RPRX vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 5.1% 4.4% 39.4% 12%
Consumer Discretionary XLY 5.3% 7.7% 52.1% 17%
Consumer Staples XLP 5.1% 6.1% 40.7% 28%
Energy XLE -1.1% 3% 38.6% 32%
Financial XLF 6.4% 8.5% 39.4% 11%
Health Care XLV 2.9% 1.6% 42.7% 40%
Industrial XLI 5.8% 5.6% 36.7% 17%
Materials XLB 5.5% 4.5% 41.4% 35%
Real Estate XLRE 4.3% 4.9% 41.2% 22%
Technology XLK 4.5% 3.9% 41.8% 31%
Utilities XLU 3.4% 5.4% 33.9% 14%
Aerospace & Defense XAR 5.8% 0.1% 25.3% -8%
Biotech XBI 5.1% -1.9% 53% 42%
Homebuilder XHB 6.4% 10.9% 57.6% 44%
Retail XRT 8.7% 6.1% 50.2% 34%

RPRX vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -7% -12.8% 32.4% 32%
Natural Gas UNG 5.6% 8.5% 23.9% 49%
Gold GLD 1.2% -0.3% 12.1% -13%
Silver SLV 5.6% -5.5% 22.6% 12%
Copper CPER 7.3% 4.2% 27.3% 26%

RPRX vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 3.3% 5.2% 43.7% 39%
iShares High Yield Corp. Bond HYG 4.3% 5.4% 38.5% 26%